These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24736356)

  • 1. The landscape of thromboprophylaxis utilization in critically ill children: sparse and variable.
    Gist KM; Chima RS
    Crit Care Med; 2014 May; 42(5):1317-8. PubMed ID: 24736356
    [No Abstract]   [Full Text] [Related]  

  • 2. A multinational study of thromboprophylaxis practice in critically ill children.
    Faustino EV; Hanson S; Spinella PC; Tucci M; O'Brien SH; Nunez AR; Yung M; Truemper E; Qin L; Li S; Marohn K; Randolph AG;
    Crit Care Med; 2014 May; 42(5):1232-40. PubMed ID: 24351371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time to recommend heparin and low-molecular-weight heparins in thromboprophylaxis in medical-surgical critically ill patients.
    Volpi N
    Crit Care Med; 2013 Sep; 41(9):2224-6. PubMed ID: 23979368
    [No Abstract]   [Full Text] [Related]  

  • 4. Heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review and meta-analysis of randomized trials.
    Alhazzani W; Lim W; Jaeschke RZ; Murad MH; Cade J; Cook DJ
    Crit Care Med; 2013 Sep; 41(9):2088-98. PubMed ID: 23782973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological and Mechanical Thromboprophylaxis in Critically Ill Patients: a Network Meta-Analysis of 12 Trials.
    Park J; Lee JM; Lee JS; Cho YJ
    J Korean Med Sci; 2016 Nov; 31(11):1828-1837. PubMed ID: 27709864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is low-molecular-weight heparin useful for venovenous hemofiltration in the intensive care unit?
    Spiegel DM; Anderson RJ
    Crit Care Med; 1999 Oct; 27(10):2316-7. PubMed ID: 10548241
    [No Abstract]   [Full Text] [Related]  

  • 7. DVT prevention. Low-molecular-weight heparin is a viable option.
    Benton L
    Am J Nurs; 2000 Feb; 100(2):84. PubMed ID: 10712165
    [No Abstract]   [Full Text] [Related]  

  • 8. Thromboprophylaxis in medical patients: the role of low-molecular-weight heparin.
    Turpie AG; Norris TM
    Thromb Haemost; 2004 Jul; 92(1):3-12. PubMed ID: 15213839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dalteparin in critically ill patients.
    Esterbrook G; Hart S
    N Engl J Med; 2011 Jul; 365(2):179; author reply 180. PubMed ID: 21751920
    [No Abstract]   [Full Text] [Related]  

  • 10. Dalteparin in critically ill patients.
    Smythe MA; Koerber JM
    N Engl J Med; 2011 Jul; 365(2):179-80; author reply 180. PubMed ID: 21751919
    [No Abstract]   [Full Text] [Related]  

  • 11. Dalteparin and heparin-induced thrombocytopenia.
    Davidson BL
    N Engl J Med; 2011 Sep; 365(12):1158; author reply 1158. PubMed ID: 21992138
    [No Abstract]   [Full Text] [Related]  

  • 12. Thromboprophylaxis for patients at high risk of VTE.
    Lowe G
    Lancet; 2008 Sep; 372(9643):1037-8. PubMed ID: 18805329
    [No Abstract]   [Full Text] [Related]  

  • 13. Venous thromboembolism prophylaxis in critically ill patients.
    McLeod AG; Geerts W
    Crit Care Clin; 2011 Oct; 27(4):765-80, v. PubMed ID: 22082513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dalteparin versus unfractionated heparin in critically ill patients.
    ; Cook D; Meade M; Guyatt G; Walter S; Heels-Ansdell D; Warkentin TE; Zytaruk N; Crowther M; Geerts W; Cooper DJ; Vallance S; Qushmaq I; Rocha M; Berwanger O; Vlahakis NE
    N Engl J Med; 2011 Apr; 364(14):1305-14. PubMed ID: 21417952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Geerts WH; Pineo GF; Heit JA; Bergqvist D; Lassen MR; Colwell CW; Ray JG
    Chest; 2004 Sep; 126(3 Suppl):338S-400S. PubMed ID: 15383478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of neuraxial anesthesia in patients receiving perioperative low-molecular-weight heparin for thromboprophylaxis.
    Llau JV
    Chest; 1999 Dec; 116(6):1843-4. PubMed ID: 10593829
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk assessment and prophylaxis of venous thromboembolism in acutely and/or critically ill patients.
    Davidson BL
    Haemostasis; 2000; 30 Suppl 2():77-81; discussion 63. PubMed ID: 11251346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboprophylaxis in arthroscopic surgery.
    Anand A
    Arthroscopy; 2014 Jul; 30(7):780. PubMed ID: 24951355
    [No Abstract]   [Full Text] [Related]  

  • 19. End of the road for heparin thromboprophylaxis.
    Linkins LA
    Blood; 2016 Apr; 127(16):1945-6. PubMed ID: 27103740
    [No Abstract]   [Full Text] [Related]  

  • 20. Thromboprophylaxis in immobilized medical patients.
    Vaitkus PT
    Eur J Med Res; 2004 Mar; 9(3):131-4. PubMed ID: 15096323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.